Legislation of proposed drug pricing should be postponed, experts said

The Korea's new drug pricing policy will have to be enacted after gaining the general consensus, which is independent from the ongoing free trade agreement with the United States, a local professor said at a forum on September 26.

Korea will carefully and exhaustively prepare strategies for the so-called positive list system to protect the position of domestic pharmaceutical industry through...